DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Rozerem (Ramelteon) - Adverse Event Reports - Serious Event - Drug Ineffective

 



Index of reports > Cases resulting in a serious event (53) > Cases with Drug Ineffective (8)

Below is the selection of adverse event reports related to Rozerem (Ramelteon) that includes cases resulting in a serious event where reactions include drug ineffective.

Adverse event in 54 year old female receiving Rozerem (Ramelteon)

Reported by a consumer/non-health professional from United States on 2007-10-16

Patient: 54 year old female, weighing 68.0 kg (149.7 pounds)

Adverse reactions / side effects: Drug Ineffective, Drug Hypersensitivity, Headache, Swollen Tongue, Ill-Defined Disorder, Pharyngeal Oedema, Hallucinations, Mixed, Insomnia, Thyroid Disorder

Adverse event resulted in: hospitalization

Suspect drug(s):
Rozerem
    Dosage: 8 mg, qhs, per oral; 8 mg, qhs, per oral; 8 mg, qhs, per oral
    Administration route: Oral
    Indication: Insomnia
    Start date: 2007-09-01
    End date: 2007-09-01

Rozerem
    Dosage: 8 mg, qhs, per oral; 8 mg, qhs, per oral; 8 mg, qhs, per oral
    Administration route: Oral
    Indication: Insomnia
    Start date: 2007-08-01

Rozerem
    Dosage: 8 mg, qhs, per oral; 8 mg, qhs, per oral; 8 mg, qhs, per oral
    Administration route: Oral
    Indication: Insomnia
    Start date: 2007-09-01

Ambien CR
    Dosage: qhs, per oral
    Administration route: Oral
    Indication: Insomnia
    Start date: 2006-01-01
    End date: 2007-09-01

Imitrex
    Dosage: 50 mg, as required, per oral; 50 mg, as required, per oral
    Administration route: Oral
    Indication: Headache
    Start date: 2003-01-01
    End date: 2007-09-01

Imitrex
    Dosage: 50 mg, as required, per oral; 50 mg, as required, per oral
    Administration route: Oral
    Indication: Headache
    Start date: 2007-09-01

Unknown Sleep Medication (All Other Therapeutic Products)
    Indication: Sleep Disorder Therapy
    Start date: 2007-08-01
    End date: 2007-08-01

Other drugs received by patient: Vicodin; Flexeril; Unknown Anti-Inflammatory (All Other Therapeutic Products); Unknown Anti-Depressant (Antidepressants)



Adverse event in 66 year old female receiving Rozerem (Ramelteon)

Reported by a physician from United States on 2007-10-09

Patient: 66 year old female, weighing 65.8 kg (144.7 pounds)

Adverse reactions / side effects: Initial Insomnia, Colon Cancer, Middle Insomnia, Drug Ineffective, Sleep Disorder

Adverse event resulted in: hospitalization

Suspect drug(s):
Rozerem
    Dosage: 8 mg, qhs, per oral; 8 mg, per oral
    Administration route: Oral
    Indication: Insomnia
    Start date: 2007-01-05
    End date: 2007-01-05

Rozerem
    Dosage: 8 mg, qhs, per oral; 8 mg, per oral
    Administration route: Oral
    Indication: Insomnia
    Start date: 2007-01-16
    End date: 2007-01-16

Other drugs received by patient: Zyrtec; Premarin; Flonase Nasal Spray (Fluticasone Propionate)



Adverse event in 54 year old female receiving Rozerem (Ramelteon)

Reported by a consumer/non-health professional from United States on 2007-10-09

Patient: 54 year old female, weighing 68.0 kg (149.7 pounds)

Adverse reactions / side effects: Drug Ineffective, Drug Hypersensitivity, Headache, Swollen Tongue, Ill-Defined Disorder, Pharyngeal Oedema, Hallucinations, Mixed, Insomnia, Thyroid Disorder

Adverse event resulted in: hospitalization

Suspect drug(s):
Rozerem
    Dosage: 8 mg, qhs, per oral; 8 mg, qhs, per oral; 8 mg, qhs, per oral
    Administration route: Oral
    Indication: Insomnia
    Start date: 2007-09-01
    End date: 2007-09-01

Rozerem
    Dosage: 8 mg, qhs, per oral; 8 mg, qhs, per oral; 8 mg, qhs, per oral
    Administration route: Oral
    Indication: Insomnia
    Start date: 2007-08-01

Rozerem
    Dosage: 8 mg, qhs, per oral; 8 mg, qhs, per oral; 8 mg, qhs, per oral
    Administration route: Oral
    Indication: Insomnia
    Start date: 2007-09-01

Ambien CR
    Dosage: qhs, per oral
    Administration route: Oral
    Indication: Insomnia
    Start date: 2006-01-01
    End date: 2007-09-01

Imitrex
    Dosage: 50 mg, as required, per oral; 50 mg, as required, oral; 50 mg, as required, per oral
    Administration route: Oral
    Indication: Headache
    Start date: 2003-01-01
    End date: 2007-09-01

Imitrex
    Dosage: 50 mg, as required, per oral; 50 mg, as required, oral; 50 mg, as required, per oral
    Administration route: Oral
    Indication: Headache
    Start date: 2007-09-01

Unknown Sleep Medication (All Other Therapeutic Products)
    Indication: Sleep Disorder Therapy
    Start date: 2007-08-01
    End date: 2007-08-01

Other drugs received by patient: Vicodin; Flexeril; Unknown Anti-Inflammatory (All Other Therapeutic Products); Unknown Anti-Depressant (Antidepressants)



Adverse event in 66 year old female receiving Rozerem (Ramelteon)

Reported by a physician from United States on 2007-05-29

Patient: 66 year old female, weighing 59.0 kg (129.7 pounds)

Adverse reactions / side effects: Drug Ineffective, Insomnia, Axillary Pain, Chest Pain, Heart Rate Irregular

Suspect drug(s):
Rozerem (Ramelteon)

Other drugs received by patient: Tylenol PM (Diphenydramine, Paracetamol); Aleve PM (Naproxen Sodium)



Adverse event in 48 year old female receiving Rozerem (Ramelteon)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-02

Patient: 48 year old female, weighing 77.1 kg (169.6 pounds)

Adverse reactions / side effects: Economic Problem, Drug Ineffective, Drug Screen Positive, Family Stress, Hallucination, Auditory, General Physical Health Deterioration, Condition Aggravated, Laceration, Intentional Self-Injury, Suicidal Ideation, Anger, Depression

Adverse event resulted in: hospitalization

Suspect drug(s):
Rozerem
    Dosage: 8 mg, 1 in 1 d, per oral
    Administration route: Oral
    Indication: Affective Disorder
    Start date: 2006-09-29
    End date: 2006-11-29

Rozerem
    Dosage: 8 mg, 1 in 1 d, per oral
    Administration route: Oral
    Indication: Insomnia
    Start date: 2006-09-29
    End date: 2006-11-29

Rozerem
    Dosage: 8 mg, 1 in 1 d, per oral
    Administration route: Oral
    Indication: Seasonal Affective Disorder
    Start date: 2006-09-29
    End date: 2006-11-29

Other drugs received by patient: Lamictal; Wellbutrin; Effexor XR; Klonopin



Adverse event in 51 year old female receiving Rozerem (Ramelteon)

Reported by a consumer/non-health professional from United States on 2007-04-04

Patient: 51 year old female, weighing 63.0 kg (138.7 pounds)

Adverse reactions / side effects: Weight Increased, Initial Insomnia, Laboratory Test Abnormal, Drug Ineffective, Thyroid Cancer, Somnolence

Adverse event resulted in: hospitalization

Suspect drug(s):
Rozerem (Ramelteon)

Other drugs received by patient: Synthroid



Adverse event in 66 year old female receiving Rozerem (Ramelteon)

Reported by a consumer/non-health professional from United States on 2007-03-16

Patient: 66 year old female, weighing 59.0 kg (129.7 pounds)

Adverse reactions / side effects: Drug Ineffective, Insomnia, Axillary Pain, Chest Pain, Heart Rate Irregular

Suspect drug(s):
Rozerem (Ramelteon)

Other drugs received by patient: Tylenol PM (Diphenhydramine, Paracetamol); Aleve PM (Naproxen Sodium)



Adverse event in 66 year old female receiving Rozerem (Ramelteon)

Reported by a individual with unspecified qualification from United States on 2007-01-26

Patient: 66 year old female, weighing 65.8 kg (144.7 pounds)

Adverse reactions / side effects: Initial Insomnia, Colon Cancer, Middle Insomnia, Drug Ineffective

Adverse event resulted in: hospitalization

Suspect drug(s):
Rozerem
    Dosage: 8 mg, qhs, per oral
    Administration route: Oral
    Indication: Insomnia
    Start date: 2007-01-05
    End date: 2007-01-05

Rozerem
    Dosage: 8 mg, qhs, per oral
    Administration route: Oral
    Indication: Insomnia
    Start date: 2007-01-16
    End date: 2007-01-16

Other drugs received by patient: Zyrtec; Premarin; Flonase Nasal Spray (Fluticasone Propionate)

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009